GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

UVSP · Sep 30, 2024

UNIVEST FINANCIAL Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000102212-24-000059Bank
Sequential deposit growth80thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.deposits

5.52% · CORE · VALID

Net-income growth65thOwn-history percentile · N=20
Evidence method

Yoy · gp.fundamentals.net_income

9.18% · CORE · VALID

Interest-income growth50thOwn-history percentile · N=20
Evidence method

Yoy · gp.financial.interest_income

9.61% · CORE · VALID

Cash and equivalents85thOwn-history percentile · N=20
Evidence method

Level · gp.fundamentals.cash

$504.7M · CORE · VALID

Sequential loan growth25thOwn-history percentile · N=20
Evidence method

Sequential · gp.financial.loans

0.69% · CORE · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History40 statesSelf-history eligible
Period transition

What moved in the state?

Deposit Growth Increased
Previous
1.40%
Current
5.52%
Delta
4.12%
Earnings Growth Increased
Previous
7.78%
Current
9.18%
Delta
1.40%
Interest Income Growth Decreased
Previous
10.75%
Current
9.61%
Delta
-1.14%
Liquidity Increased
Previous
$190.9M
Current
$504.7M
Delta
$313.8M
Loan Growth Decreased
Previous
1.63%
Current
0.69%
Delta
-0.94%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.